title: Loss of effector function of human cytolytic T lymphocytes is accompanied by major alterations in N- and O-glycosylation.
abstract: Most human tumors are not eliminated by the immune system, and therapeutic vaccination shows poor results, a fact that can be explained at least partially by an immunosuppressive tumor microenvironment that is abundant in galectin-3. On cytolytic T lymphocyte (CTL) clones, maintained in culture by regular stimulation, recently activated CTLs present low effector functions. However, these functions are restored after a short treatment with LacNAc. The latter, which is in agreement with the glycoprotein-galectin lattice concept involving reduced motility, poses the question why galectin-3 ligands improve effector functions. We employed ultrasensitive MALDI-TOF-MS on resting and recently activated CTL clones combined with various glycosidase digestions and GC-MS linkage analyses. Our results showed that compared with the resting CTLs, the N-glycans of the recently activated CTLs consisted of (i) larger LacNAc oligomers of which a significant portion was longer than four-units and (ii) more multi-antennary structures. Interestingly, our results showed that the poly-LacNAc appeared to be equally distributed on all available N-glycan branches and not selectively enriched on a specific branch. The above structural alterations in the recently activated CTLs are expected to increase the galectin-3-LacNAc lattices and multivalent interactions and, therefore, reduce the motility of surface glycoproteins, such as the T-cell receptor. These findings suggest that the loss of effector functions on CTLs may be linked to reduced motility of surface glycoproteins. In addition, our results showed that recently activated CTLs had a reduced abundance of NeuAcα2,6-linked N-glycans and an increased abundance of disialylated core 1 and monosialylated core 2 O-glycan structures.
authors.affiliation: Division of Molecular Biosciences, Imperial College London, London SW7 2AZ, United Kingdom.
authors.forename: Aristotelis
authors.initials: A
authors.lastname: Antonopoulos
authors.forename: Nathalie
authors.initials: N
authors.lastname: Demotte
authors.forename: Vincent
authors.initials: V
authors.lastname: Stroobant
authors.forename: Stuart M
authors.initials: SM
authors.lastname: Haslam
authors.forename: Pierre
authors.initials: P
authors.lastname: van der Bruggen
authors.forename: Anne
authors.initials: A
authors.lastname: Dell
mesh_terms: D000606:Amino Sugars / Q000737:chemistry; D000818:Animals; D002999:Clone Cells / Q000276:immunology / Q000378:metabolism; D000939:Epitopes / Q000378:metabolism; D037502:Galectin 3 / Q000378:metabolism; D054794:Glycomics; D006026:Glycoside Hydrolases / Q000378:metabolism; D006031:Glycosylation; D006801:Humans; D008024:Ligands; D019158:N-Acetylneuraminic Acid / Q000378:metabolism; D009584:Nitrogen; D010100:Oxygen; D011134:Polysaccharides / Q000737:chemistry / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism*
chemical_list: D000606:Amino Sugars; D000939:Epitopes; D037502:Galectin 3; D008024:Ligands; D011134:Polysaccharides; C066929:polylactosamine; D006026:Glycoside Hydrolases; C026093:keratan-sulfate endo-1,4-beta-galactosidase; D019158:N-Acetylneuraminic Acid; D009584:Nitrogen; D010100:Oxygen